In Silico Study of Curcuminoid Compounds in Turmeric ( Curcuma longa) Plants as Halal Anticoagulant Active Ingredients
Abstract
Full Text:
PDFReferences
1. Mackman N. New insights into the mechanisms of venous thrombosis. J Clin Invest. 2012;122(7):2331–6.
2. Etikasari E, Chayati N. Screening Risiko Terjadinya Deep Vein Trhombosis. J Telenursing. 2021;3:6.
3. Saliba MJ. Heparin in the treatment of burns: A review. Burns. 2001;27(4):349–58.
4. ALkharashi NA. Brief communication. Saudi Med J. 2019;40(12):1290–3.
5. Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: Diagnosis and management update. Postgrad Med J. 2007;83(983):575–82.
6. Liu H, Zhang Z, Linhardt RJ. Lessons learned from the contamination of heparin. Nat Prod Rep. 2009;26(3):313–21.
7. Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45(4):221–6.
8. Jain AN, Nicholls ÆA. Recommendations for evaluation of computational methods. 2008;(February):133–9.
9. CLC Bio Company. Molegro virtual docker user manual. User Man. 2012;0:327.
10. El-Din HMA, Loutfy SA, Fathy N, Elberry MH, Mayla AM, Kassem S, et al. Molecular docking based screening of compounds against VP40 from Ebola virus. Bioinformation. 2016;12(3):192–6.
11. Kartasasmita RE, Anugrah R, Tjahjono DH. Kajian Docking Dan Prediksi Beberapa Aspek Farmakokinetika Desain Molekul Turunan Kuinin Sebagai Upaya Menemukan Kandidat Senyawa Antimalaria yang Baru. Kartika J Ilm Farm. 2015;3(1):13–20.
12. Mutiah R, Firdausy AF, Indrawijaya YYA, Hibbbatullah H. In Silico Prediction of Heliannuol A, B, C, D, and E Compounds on Estrogen Receptor β Agonists. Indones J Cancer Chemoprevention. 2021;12(1):37.
13. Chagas CM, Moss S, Alisaraie L. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. Int J Pharm [Internet]. 2018;549(1–2):133–49. Available from:https://doi.org/10.1016/j.ijpharm.2018.07.046
14. Amin ML. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights. 2013;2013(7):27–34.
15. Alfaini RW. Studi In Silico Aktivitas Antimalaria Metabolit Sekunder Kulit Batang Pulai (Alstonia Scholaris) Terhadap Berbagai Target Protein Plasmodium falciparum. Universitas Brawijaya. Universitas Brawijaya; 2022.
16. Mutiah R, Dewi TJD, Suryadinata A, Qonita K. Inhibition of Human Epidermal Growth Factor Receptor-2 (HER-2) from Pomelo (Citrus maxima) Flavonoid Compounds: an In Silico Approach. Indones J Cancer Chemoprevention. 2021;12(3):148.
17. Muti’ah R, Rahmawati EK, Dewi TJD, Firdausy AF. In Silico Prediction of The Antiangiogenesis Activity of Heliannuol Lactone sesquiterpenes Compounds from Sunflower (Heliannthus annuus L.). Indones J Cancer Chemoprevention. 2021;12(2):90.
18. Jati T, Dewi D. In Silico Study of Novel Ketorolac as selective Cyclooxygenase-2. 2022;2:93–107.
19. Qu SY, Xu Q, Wu W, Li F, Li CD, Huang R, et al. An unexpected dynamic binding mode between coagulation factor X and Rivaroxaban reveals importance of flexibility in drug binding. Chem Biol Drug Des. 2019;94(3):1664–71.
20. Zhang W, Swanson R, Izaguirre G, Xiong Y, Lau LF, Olson ST. The heparin-binding site of antithrombin is crucial for antiangiogenic activity. Blood. 2005;106(5):1621–8.
21. Puspaningtyas AR. Docking Dengan Molegro.Pdf. 2012. p. 31–9.
22. Kesuma D, Siswandono S, Purwanto BT, Hardjono S. Uji in silico Aktivitas Sitotoksik dan Toksisitas Senyawa Turunan N-(Benzoil)-N’- feniltiourea Sebagai Calon Obat Antikanker. Journal of Pharmaceutical Science and Clinical Research. 2018;3(1):1.
DOI: https://doi.org/10.18860/jim.v7i2.24568
Refbacks
- There are currently no refbacks.
Editorial Office:
Faculty of Medical and Health Sciences,
Universitas Islam Negeri Maulana Malik Ibrahim
Gedung Ibnu Thufail Lt.1, Jln. Locari, Desa Tlekung, Kota Batu
Phone (+62) 85746163772, (+62) 8563588384, Faximile (+62) 341 558933
e-mail: medicaljournal@uin-malang.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.